Keymed Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	21,653	15,746	8,516	13,586	14,174	9,651
Market Cap Growth	79.17%	84.90%	-37.32%	-4.15%	46.87%	-
Enterprise Value	20,391	13,639	6,526	10,725	10,331	15,170
Last Close Price	73.50	53.45	30.90	49.10	51.00	34.50
PS Ratio	27.16	19.75	18.69	34.83	125.30	71.30
PB Ratio	7.01	5.10	3.23	4.13	3.76	2.16
P/TBV Ratio	7.03	5.12	3.25	4.13	3.76	2.15
EV/Sales Ratio	25.58	17.11	14.32	27.49	91.33	112.08
Debt / Equity Ratio	0.28	0.28	0.30	0.14	0.04	0.01
Net Debt / Equity Ratio	-0.41	-0.41	-0.57	-0.77	-0.91	-0.96
Net Debt / EBITDA Ratio	2.04	2.04	2.55	5.67	5.85	10.02
Net Debt / FCF Ratio	-	-	1.41	3.37	4.49	9.02
Asset Turnover	0.18	0.18	0.11	0.09	0.03	0.05
Inventory Turnover	0.55	0.55	0.13	0.66	0.07	1.02
Quick Ratio	2.42	2.42	3.04	8.80	8.45	31.55
Current Ratio	2.90	2.90	3.30	9.36	8.72	31.96
Return on Equity (ROE)	-19.91%	-19.91%	-18.85%	-11.31%	-8.69%	-305.24%
Return on Assets (ROA)	-9.88%	-9.88%	-10.23%	-7.32%	-8.65%	-10.09%
Return on Capital Employed (ROCE)	-18.70%	-18.70%	-20.70%	-12.80%	-15.30%	-9.40%
Earnings Yield	-2.69%	-3.69%	-6.44%	-2.91%	-2.46%	-49.44%
FCF Yield	-	-	-12.46%	-5.53%	-5.43%	-4.92%
Buyback Yield / Dilution	-4.59%	-4.59%	-0.22%	-0.09%	-62.34%	-139.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.